Not released until Thursday, the CEO of Pfizer, Albert Bourla, is noted as saying as early as April 1st that the COVID-19 vaccination shot may become an annual shot that will be needed 12 months after taking the second shot.
Bourla spoke with CNBC‘s Bertha Coombs at a CVS Health event, “A likely scenario is that there will be likely a need for a third dose, somewhere between six and 12 months and then from there, there will be an annual revaccination, but all of that needs to be confirmed. And again, the variants will play a key role.”
Though Pfizer is proven to be 91% effective and more than 95% effective up to six months after the second dose. The vaccinations research was conducted on over 12,000 volunteers, but more research needs to be conducted to determine how effective the vaccinations last after six months.